Oxygenation and A2AR Blockade to Eliminate Hypoxia/HIF-1α–Adenosinergic Immunosuppressive Axis and Improve Cancer Immunotherapy
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Current Opinion in Pharmacology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Oxygenation and A2AR Blockade to Eliminate Hypoxia/HIF-1α-Adenosinergic Immunosuppressive Axis and Improve Cancer Immunotherapy
Curr Opin Pharmacol 2020 Aug 01;53(xx)84-90, K Halpin-Veszeleiova, SM HatfieldFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.